LexisNexis® CLE On-Demand features premium content from partners like American Law Institute Continuing Legal Education and Pozner & Dodd. Choose from a broad listing of topics suited for law firms, corporate legal departments, and government entities. Individual courses and subscriptions available.
By Savaria B. Harris and Mitka T. Baker
Forbes magazine has dubbed 2014 “The Year of the Whistleblower.” For healthcare providers, this designation has translated into millions of dollars in fines and penalties and the initiation of criminal investigations.
Just last month, the Health Care Fraud Prevention and Enforcement Action Team (HEAT), settled a whistleblower-initiated lawsuit filed against a healthcare provider for $350 million to resolve claims that it violated the False Claims Act by paying physicians kickbacks to induce the referral of patients to its dialysis clinics. The provider also agreed to forfeit $39 million based on conduct related to two transactions of its joint venture.
Healthcare providers are under growing scrutiny as government regulators become more aggressive in their pursuit of healthcare fraud. Headlines spouting promises of increased criminal prosecutions of individuals, commitments to protect taxpayer dollars and changes to the laws making it easier for whistleblowers to bring healthcare fraud claims have become the norm.
The regulators’ enforcement tool of choice? The federal False Claims Act.
In 2013, the Department of Justice recovered $2.6 billion for violations of the FCA relating to healthcare fraud, making it the fourth consecutive year in which the DOJ has collected over $2 billion from organizations and individuals in the healthcare industry. FCA settlements involving alleged violations by hospitals, nursing homes, skilled care facilities, physician practices or other healthcare providers totaled more than 40, with individual settlement amounts reaching as high as $48 million. The DOJ also obtained a $237 million judgment against a healthcare system after a four-week trial for violating the Stark Law and the FCA.
The government HEAT
HEAT, a joint initiative between the DOJ and US Department of Health and Human Services, leads the government’s investigation of Medicare and Medicaid financial fraud. On the federal level, HEAT acts through its Medicare Fraud Strike Force, which analyzes Medicare claims data to target geographic areas showing unusually high levels of Medicare billing. In 2013, the Strike Force filed 137 cases, charged 345 individuals, secured 234 guilty pleas and won 46 jury trial convictions.
HEAT is also assisted by state Medicaid Fraud Control Units (MFCUs), which are charged with investigating and prosecuting Medicaid fraud, as well as patient abuse and neglect in healthcare facilities. The MFCUs are made up of attorney-led teams of investigators and auditors.
Increased FCA risks for healthcare providers
Traditionally, FCA actions have been brought against healthcare providers for allegedly engaging in the following actions:
Healthcare providers’ risk of violating the FCA, however, significantly increased after the enactment of the Patient Protection and Affordable Care Act of 2010. Under the ACA and its implementing regulations, an FCA violation can be based on a violation of the Anti-Kickback Statute and a failure to return Medicare overpayments within 60 day of identifying them. The ACA also limited the scope of the “public disclosure” defense to FCA claims, making it easier for whistleblowers and the government to avoid a jurisdictional bar to their lawsuit.
The HHS Office of Inspector General Work Plan for Fiscal Year 2015, which summarizes new and ongoing reviews and activities it plans to pursue, shows that OIG will be increasing its scrutiny and review of ACA spending and Medicare billing. Among other things, the 2015 Work Plan calls for at least 5-10 additional reviews addressing ACA programs and the review of the billing and payment policies and procedures used by healthcare providers.
Individuals also face an increased risk of violating the FCA. Cases involving fraud by executives at healthcare providers are now a high priority for the DOJ’s Criminal Division, which is now reviewing qui tam complaints as soon as they are filed to determine whether or not to bring parallel criminal proceedings.
State false claims statutes – often as strong as the federal FCA
Healthcare providers must also be wary about violating individual state false claims statutes. In 2013, states recovered $443 million for violations of state Medicaid programs. To date, 30 states, among them New York, California and Virginia, have false claim statutes, and the number of states FCAs are expected to grow. Eighteen states have been deemed by HHS to have false claims statutes at least as strong as the FCA because they (1) contain provisions rewarding and facilitating qui tam actions, (2) allow actions to be filed under seal for 60 days with review by the State Attorney General and (3) contain civil penalties equal to or greater than the FCA.
What can healthcare providers do about their FCA risk? 5 action steps
Under section 6401(a) of the ACA, compliance programs that contain certain “core elements” are a condition of participation in Medicare, Medicaid and Children’s Health Insurance Program. Below are key steps healthcare providers can take to minimize their FCA risks:
1. Identify the risk areas
2. Establish internal controls
3. Conduct trainings
4. Utilize internal whistleblowers
5. Partner with outside counsel
To learn more about the potential impact of the False Claims Act on your health system, please contact the authors.
Published by DLA Piper LLP (US) Copyright © 2014 DLA Piper LLP (US) All Rights Reserved This bulletin is intended as a general overview and discussion of the subjects dealt with. It is not intended, and should not be used, as a substitute for taking legal advice in any specific situation. DLA Piper will accept no responsibility for any actions taken or not taken on the basis of this publication. Pursuant to applicable Rules of Professional Conduct, it may constitute advertising. Circular 230 Notice: In compliance with US Treasury Regulations, please be advised that any tax advice given herein (or in any attachment) was not intended or written to be used, and cannot be used, for the purpose of (i) avoiding tax penalties or (ii) promoting, marketing or recommending to another person any transaction or matter addressed herein. DLA Piper LLP (US) is part of DLA Piper, a global law firm, operating through various separate and distinct legal entities. Further details of these entities can be found at www.dlapiper.com. All rights reserved.
For more information about LexisNexis products and solutions, connect with us through our corporate site.